Clinical Trials in Baltimore

Showing 7561-7580 of 23,476 trials

Skeletal Metastasis Registry

NCT05058014

This is a prospective, observational study designed to contribute data from patients with symptomatic metastatic bone disease treated at Sibley Memorial Hospital and Johns Hopkins Medicine to an international registry hosted by the Swedish Regional Cancer Centrum in Stockholm, Sweden. This protocol supports a worldwide effort to collect and store information from patients treated for symptomatic bone metastases within the International Skeletal Metastasis Registry (ISMR)

Metastatic Bone Tumor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins50 participantsStarted Aug 2018

Baltimore, Maryland, United States

Active Not RecruitingPhase 1/2< 1 mile

Durvalumab and Tremelimumab for Pediatric Malignancies

NCT03837899

The purpose of the study is to determine the recommended dose of durvalumab and tremelimumab (immunotherapy drugs) in pediatric patients with advanced solid and hematological cancers and expand in a second phase to test the efficacy of these drugs once this dose is determined.

Pediatric CancerSolid Tumor PediatricHematological Malignancies

AstraZeneca50 participantsStarted Mar 2019

Baltimore, Maryland, United States • Boston, Massachusetts, United States • New Hyde Park, New York, United States +16 more locations

Skeletal Metastasis Registry

Durvalumab and Tremelimumab for Pediatric Malignancies

Find Trials by Condition in Baltimore

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6)

A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy

Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants

Promoting Recovery Optimization With WALKing Exercise After Stroke

Network Interventions to Reduce Disparities in Living Kidney Donation

An Extension Study to Assess Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-4)

A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia

ABC008 in Subjects with T-cell Large Granular Lymphocytic Leukemia (T-LGLL)

A Study of LY3022855 In Participants With Breast or Prostate Cancer

Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma

Study of Zanubrutinib (BGB-3111) in Participants With Marginal Zone Lymphoma

A Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant Melanoma

The PRISM Intervention for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation

Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric Cancer

A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

Study of Ociperlimab Plus Tislelizumab Plus Chemoradiotherapy in Participants With Untreated Limited-Stage Small Cell Lung Cancer

Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms